Search Results - "KROL, GREGORY"

Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication by Schaefer, Jordan K, Errickson, Josh, Li, Yun, Kong, Xiaowen, Alexandris-Souphis, Tina, Ali, Mona A, Decamillo, Deborah, Haymart, Brian, Kaatz, Scott, Kline-Rogers, Eva, Kozlowski, Jay H, Krol, Gregory D, Shankar, Sahana R, Sood, Suman L, Froehlich, James B, Barnes, Geoffrey D

“…It is unclear how many patients treated with a direct oral anticoagulant (DOAC) are using concomitant acetylsalicylic acid (ASA, or aspirin) and how this…”
Get more information

Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events by Schaefer, Jordan K, Li, Yun, Gu, Xiaokui, Souphis, Nicole M, Haymart, Brian, Kline-Rogers, Eva, Almany, Steven L, Kaatz, Scott, Kozlowski, Jay H, Krol, Gregory D, Sood, Suman L, Froehlich, James B, Barnes, Geoffrey D

“…It is not clear how often patients receive aspirin (acetylsalicylic acid) while receiving oral anticoagulation with warfarin sodium without a clear therapeutic…”
Get more information

Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach by Dawson, Taylor, DeCamillo, Deborah, Kong, Xiaowen, Shensky, Brian, Kaatz, Scott, Krol, Gregory D, Ali, Mona, Haymart, Brian, Froehlich, James B, Barnes, Geoffrey D

Get full text

Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “Real-World” Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials by Hughey, Andrew B., Gu, Xiaokui, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Besley, Dennis, Krol, Gregory D., Ahsan, Syed, Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.

“…Randomized controlled trials (RCTs) examining warfarin use for stroke prevention in atrial fibrillation (AF) may not accurately reflect real-world populations…”
Get full text

Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant by Hale, Zachary D., Kong, Xiowen, Haymart, Brian, Gu, Xiaokui, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D., Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.

“…Direct oral anticoagulant (DOAC) agents offer several lifestyle and therapeutic advantages for patients relative to warfarin in the treatment of atrial…”
Get full text

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation by Schaefer, Jordan K., Errickson, Josh, Gu, Xiaokui, Alexandris-Souphis, Tina, Ali, Mona A., Haymart, Brian, Kaatz, Scott, Kline-Rogers, Eva, Kozlowski, Jay H., Krol, Gregory D., Shah, Vinay, Sood, Suman L., Froehlich, James B., Barnes, Geoffrey D.

“…ImportanceFor some patients receiving warfarin, adding aspirin (acetylsalicylic acid) increases bleeding risk with unclear treatment benefit. Reducing excess…”
Get full text

SAME-TT2R2 PREDICTS QUALITY OF ANTICOAGULATION IN PATIENTS WITH VENOUS THROMBOEMBOLISM: THE MAQI2 EXPERIENCE by Kataruka, Akash, Kong, Xiaowen, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D, Kaatz, Scott, Froehlich, James, Barnes, Geoffrey

“…Conclusions The SAMe-TT2R2 score has modest predictive ability for INR quality and adverse clinical events among warfarin-treated VTE patients…”
Get full text

Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study by Schaefer, Jordan K., Errickson, Josh, Kong, Xiaowen, Ali, Mona A., DeCamillo, Deborah, Edupuganti, Subhash, Haymart, Brian, Kaatz, Scott, Kline-Rogers, Eva, Kozlowski, Jay H., Krol, Gregory D., Sood, Suman L., Froehlich, James B., Barnes, Geoffrey D.

“…For patients anticoagulated with direct oral anticoagulants (DOACs) or warfarin and on aspirin (ASA) for nonvalvular atrial fibrillation and/or venous…”
Get full text

SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience by Kataruka, Akash, Kong, Xiaowen, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D, Kaatz, Scott, McNamara, Michael W, Froehlich, James B, Barnes, Geoffrey D

“…A high SAMe-TT2R2 score predicted poor warfarin control and adverse events among atrial fibrillation patients. However, the SAMe-TT2R2 score has not been well…”
Get full text

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics by Barnes, Geoffrey D, Misirliyan, Sevan, Kaatz, Scott, Jackson, Elizabeth A, Haymart, Brian, Kline-Rogers, Eva, Kozlowski, Jay, Krol, Gregory, Froehlich, James B, Sales, Anne

“…Patients on chronic warfarin therapy require regular laboratory monitoring to safely manage warfarin. Recent studies have challenged the need for routine…”
Get full text

Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes by Remer, Hallie B., Gu, Xiaokui, Haymart, Brian, Barnes, Geoffrey D., Ali, Mona A., Kline-Rogers, Eva, Alexandris-Souphis, Tina, Kozlowski, Jay H., Froehlich, James B., Shah, Vinay, Krol, Gregory D., Kaatz, Scott

“…Patients' international normalized ratios (INRs) often fall slightly out of range. In these cases, the American College of Chest Physicians (ACCP) guidelines…”
Get full text

Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant by Minhas, Anum S., Jiang, Qingmei, Gu, Xiaokui, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D., Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.

“…All available direct oral anticoagulants (DOACs) are at least partially eliminated by the kidneys. These agents are increasingly being used as alternatives to…”
Get full text

A Rare Case of Intraductal Papillary Mucinous Neoplasm of the Biliary Duct in a Patient with Prostate Adenocarcinoma by Parekh, Ravish, Krol, Gregory, Piraka, Cyrus, Batra, Surinder

“…Intraductal papillary mucinous neoplasms (IPMNs) are mucin-producing papillary neoplasms of the pancreatic or biliary ductal system that exhibit variable…”
Get full text

WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION: COMPARISON OF PATIENT CHARACTERISTICS AND OUTCOMES OF THE “REAL-WORLD” MICHIGAN ANTICOAGULATION QUALITY IMPROVEMENT INITIATIVE (MAQI2) REGISTRY TO THE RE-LY, ROCKET-AF, AND ARISTOTLE TRIALS by Hughey, Andrew, Barnes, Geoffrey, Gu, Xiaokui, Haymart, Brian, Kline-Rogers, Eva, Almany, Steven, Kozlowski, Jay, Besley, Dennis, Krol, Gregory D, Ahsan, Syed, Kaatz, Scott, Froehlich, James

Get full text

Clinical and safety impact of an inpatient Pharmacist-Directed anticoagulation service by Schillig, Jessica, Kaatz, Scott, Hudson, Michael, Krol, Gregory D., Szandzik, Edward G., Kalus, James S.

“…BACKGROUND: Warfarin is implicated in approximately 30% of reported anticoagulant‐related errors. In order to improve anticoagulation management and safety,…”
Get full text

The changing characteristics of atrial fibrillation patients treated with warfarin by Putnam, Andrew, Gu, Xiaokui, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D., Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.

“…It has been suggested that direct oral anticoagulants are being preferentially used in low risk atrial fibrillation (AF) patients. Understanding the changing…”
Get full text

Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants by Schaefer, Jordan K., Sood, Suman L., Haymart, Brian, Gu, Xiaokui, Kong, Xiaowen, Kline-Rogers, Eva, Almany, Steven, Kozlowski, Jay, Krol, Gregory D., Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.

“…Clinical factors and patient preferences are important for selecting oral anticoagulants for venous thromboembolism (VTE) and atrial fibrillation (AF). The…”
Get full text

Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience by Barnes, Geoffrey D, Kaatz, Scott, Lopez, Alexis, Gu, Xiaokui, Kozlowski, Jay, Krol, Gregory D, Froehlich, James B

Get more information

The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience by Barnes, Geoffrey D., Gu, Xiaokui, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Besley, Dennis, Krol, Gregory D., Froehlich, James B., Kaatz, Scott

“…Guidelines recommend the assessment of stroke and bleeding risk before initiating warfarin anticoagulation in patients with atrial fibrillation. Many of the…”
Get full text

A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism by Schaefer, Jordan K, Errickson, Josh, Kong, Xiaowen, Ali, Mona A, Chipalkatti, Naina, Haymart, Brian, Kaatz, Scott, Krol, Gregory D, Sood, Suman L, Froehlich, James, Barnes, Geoffrey D.

“…Introduction Apixaban and rivaroxaban are the most commonly used direct oral anticoagulants (DOACs) for atrial fibrillation (AF) and venous thromboembolism…”
Get full text